Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CA9 | Q16790 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Amylene Hydrate SCHEMBL5546962 | 0.84 | CA12 (0.35) | ALDH1A1CA12CA1CA2CA9 | |
| SCHEMBL9315416 | 0.83 | ALDH1A1 (0.56) | ALDH1A1MEN1KMT2A | |
| SCHEMBL6899908 | 0.82 | ESR1 (0.34) | ALDH1A1TDP1KMT2A | |
| SCHEMBL2740455 | 0.81 | ALDH1A1 (0.36) | ALDH1A1CA12CA1CA2CA9 | |
| SCHEMBL6259993 | 0.80 | ALDH1A1 (0.53) | ALDH1A1MEN1KMT2A | |
| SCHEMBL24090272 | 0.79 | ALDH1A1 (0.34) | ALDH1A1CA12CA1CA2CA9 | |
| SCHEMBL13592112 | 0.79 | ALDH1A1 (0.34) | ALDH1A1CA12CA1CA2CA9 | |
| SCHEMBL11761225 | 0.78 | ALOX15 (0.56) | TDP1MEN1CYP3A4ALOX15KMT2A | |
| SCHEMBL145851 | 0.77 | CA12 (0.34) | ALDH1A1CA12CA1CA2CA9 | |
| SCHEMBL27570999 | 0.77 | ALDH1A1 (0.38) | ALDH1A1CA12CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6416773-B2 | MIXTURE OF 3,3-DIPHENYLACRYLATE AND DIBENZOYLMETHANE COMPOUND | BASF AKTIENGESELLSCHAFT (DE) | 2002-07-09 | — | — | US | disclosed |
| US-20010028888-A1 | Cosmetic or dermatological light protection agent preparations | BASF AKTIENGESELLSCHAFT (DE) | 2001-10-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010028888-A1 | Cosmetic or dermatological light protection agent preparations | DSG1, DDT, CUTA | ALDH1A1 15/4885CA12 3308/4885CA1 3723/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.